Skip to main content
SpringerLink
Log in

Impurity Profiling of Novel Oxazolidinone Antibacterial Agent: WCK 4086

  • Original
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

WCK 4086 is new antibacterial drug being developed to treat infections caused by Gram positive bacteria. This study describes development of mass spectrometry (MS) compatible reversed phase liquid chromatographic method for separation, identification and quantification of the related compounds in WCK 4086. Four process related compounds and seven degradation products (DPs) were separated and structurally identified with the use of liquid chromatography tandem mass spectrometry. Three process-related compounds were synthesized and characterized using MS and nuclear magnetic resonance spectrometry. Acid/base hydrolysis produced three DPs and oxidation produced four DPs. Method validation activity was performed to increase the acceptability of the developed method. The method was precise and accurate; accuracy exceeded 97.04% with a precision of less than 5.55%. The impurities could be detected as low as 0.05 µg mL−1. The methodology was used for the batch release and stability studies of the WCK 4086 used in the preclinical studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Gray EZ, Charles WF, Douglas KH, Steven JB, Michael RB (1997) Development of the clinical candidate’s eperezolid and linezolid. Expert Opin Investig Drugs 6(2):151–158. https://doi.org/10.1517/13543784.6.2.1511

    Article  Google Scholar 

  2. Kanafani ZA, Corey GR (2012) Tedizolid (TR-701): a new Oxazolidinone with enhanced potency. Expert Opin Investig Drugs 21(4):515–522. https://doi.org/10.1517/13543784.2012.660250

    Article  PubMed  CAS  Google Scholar 

  3. Shuan W, Xiaopan G, Weijie Z, Fengmin H, Guanglu J, Lingling D, Liping Z, Fen W, Xia Y, Hairong H (2020) In Vitro efficacy comparison of linezolid, tedizolid, sutezolid and delpazolid against rapid growing mycobacteria isolated in Beijing, China. BioRxiv. https://doi.org/10.1101/2020.06.25.172742

    Article  Google Scholar 

  4. Patil VJ, Hangarge RV, Munshi AB, Loganathan V, Trivedi BK (2012) Process for the preparation of phosphoric acid mono- (l-{4- [(s) -5- (acetylaminomethyl) - 2 - oxo - oxazolidin- 3 - yl] - 2, 6 - difluorophenyl} - 4 -methoxymethylpiperidin- 4 - yl) ester. US Patent WO 2012059823 A1

  5. Patil VJ, Patel MV, Trivedi BK, Dekhane DV, Shaikh, MU, Chugh Y, Chavan RP, Jafri MA (2012) Substituted piperidino phenyloxazolidinones. US Patent US8288416 B2

  6. Patel MV, Phansalkar M, Patil VJ, Sindkhedkar MD, Deshpande PK (2012) Substituted piperidino phenyloxazolidinones. US Patent US8217058B2

  7. Chugh Y, Shetty N, Deshpande P, Sindkhedkar M, Jafri M, Gupte S, Patel M, Des Souza N (2004) Substituted piperidino phenyl oxazolidinones having antimicrobial activity with improved in vivo efficacy. US Patent US20100144735-A1

  8. Rane VP, Ahirrao VK, Patil KR, Jadhav RA, Yeole RD (2020) Impurity profiling of a novel β-Lactam enhancer: zidebactam. Chromatographia 83:423–437. https://doi.org/10.1007/s10337-019-03845-3

    Article  CAS  Google Scholar 

  9. Ahirrao VK, Rane VP, Patil KR, Jadhav RA, Shinde VA, Deshmukh VV, Dabhade SK, Kale RP, Gupta SV, Yeole RD (2019) Identification and quantification of related impurities of a novel ketolide antibiotic nafithromycin. Chromatographia 82:1059–1068. https://doi.org/10.1007/s10337-019-03743-8

    Article  CAS  Google Scholar 

  10. ICH guideline (2006) Q3 (R2) Impurities in new drug substance, International Conference on Harmonization, IFPMA, Geneva

  11. ICH guideline (1999) Q6A Specifications: Test procedure and Acceptance Criteria for New drug substance and New drug products: Chemical substance: International Conference on Harmonization, IFPMA, Geneva

  12. Ahirrao VK, Rane VP, Patil KR, Patil VJ, Yeole RD, Patel MV (2018) Development and validation of the chiral liquid chromatography method for separation of enantiomeric impurity in novel oxazolidinone antibacterial agent WCK4086. J Chromatogr Sci 56(9):789–793. https://doi.org/10.1093/chromsci/bmy052

    Article  PubMed  CAS  Google Scholar 

  13. Ahirrao V, Rane V, Patil K, Jadhav R, Patel A, Patil V, Yeole R (2019) Chiral separation and thermodynamic investigation of WCK 3023: a novel oxazolidinone antibacterial agent, application to pre-clinical pharmacokinetic study. Biomed Chromatogr. https://doi.org/10.1002/bmc.4566

    Article  PubMed  Google Scholar 

  14. Blessy M, Patel RD, Prajapati PN, Agrawal YK (2014) Development of forced degradation and stability indicating studies of the drugs—a review. J Pharm Anal 4(3):159–165. https://doi.org/10.1016/j.jpha.2013.09.003

    Article  PubMed  CAS  Google Scholar 

  15. ICH guideline (1996) Photo-stability testing of new drug substances and drug products, Q1B). In: International Conference on Harmonization, IFPMA, Geneva

  16. Lories IB (2003) Stability-indicating methods for the determination of linezolid in the presence of its alkaline-induced degradation products. Talanta 60:945–953. https://doi.org/10.1016/S0039-9140(03)00175-9

    Article  CAS  Google Scholar 

  17. Yinping L, Bo J, Chen M, Tingting Z, Tong L (2017) Identification of forced degradation products of tedizolid phosphate by liquid chromatography/electrospray ionization tandem mass spectrometry. J Pharm Biomed Anal 239:221–231. https://doi.org/10.1016/j.jpba.2017.03.006

    Article  CAS  Google Scholar 

  18. Kaijing G, Tingting Z, Yanan W, Bo J, Chen M (2019) Characterization of degradation products and process-related impurity of sutezolid by liquid chromatography/ electrospray ionization tandem mass spectrometry. J Pharm Biomed Anal 169:196–207. https://doi.org/10.1016/j.jpba.2019.03.005

    Article  CAS  Google Scholar 

  19. ICH guideline (2005) Validation of analytical procedures: text and methodology, Q2 (R1). In: International Conference on Harmonization, IFPMA, Geneva

Download references

Acknowledgements

The authors thank the management of Wockhardt Limited for the facility and encouragement to support the drug discovery research.

Funding

The research work presented in this manuscript is a part of drug discovery research program of Wockhardt Limited.

Author information

Authors and Affiliations

  1. Wockhardt Research Centre, D-4, MIDC, Chikalthana, Aurangabad, 431006, India

    Vinod K. Ahirrao, Rushikesh H. Patil, Amin R. Pathan, Kiran R. Patil, Vipul P. Rane & Ravindra D. Yeole

Authors
  1. Vinod K. Ahirrao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rushikesh H. Patil
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amin R. Pathan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kiran R. Patil
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Vipul P. Rane
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ravindra D. Yeole
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vinod K. Ahirrao.

Ethics declarations

Conflict of interest

The presented work is original research work of Wockhardt Limited and all the authors are employees of Wockhardt Limited.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ahirrao, V.K., Patil, R.H., Pathan, A.R. et al. Impurity Profiling of Novel Oxazolidinone Antibacterial Agent: WCK 4086. Chromatographia 84, 1121–1130 (2021). https://doi.org/10.1007/s10337-021-04095-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10337-021-04095-y

Keywords

Search

Navigation